← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Raft Pharmaceuticals, Llc
San Diego, CA
$7,557,200
Total funding
6
Grants
Funding over time
peak $2.7M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,557,200 · 6
By mechanism
R44$5,093,561 · 2
R41$1,765,603 · 3
R42$698,036 · 1
Investigators at Raft Pharmaceuticals, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Novel biologic to treat chemotherapy-induced neuropathic pain$1,049,997
R44 · FY2023 · CA
Targeting lipid rafts for treatment of asthma$1,046,403
R44 · FY2025 · AI
Targeting lipid rafts for treatment of asthma$999,991
R44 · FY2023 · AI
Novel biologic to treat chemotherapy-induced neuropathic pain$999,967
R44 · FY2022 · CA
Targeting lipid rafts for treatment of asthma$997,203
R44 · FY2024 · AI
Targeting lipid rafts for treatment of migraine$665,674
R41 · FY2019 · NS
Targeting TLR4-lipid rafts to prevent postoperative pain$414,835
R42 · FY2023 · NS
Targeting lipid rafts for treatment of asthma$299,989
R41 · FY2020 · AI
Targeting lipid rafts for treatment of asthma$299,940
R41 · FY2019 · AI
Targeting TLR4-lipid rafts to prevent postoperative pain$283,201
R42 · FY2024 · NS
AAV-AIBP Therapy for Alzheimer's Disease$252,944
R41 · FY2023 · AG
AAV-AIBP Therapy for Alzheimer's Disease$247,056
R41 · FY2022 · AG